Abstract
The effects of intracerebroventricular injection of neuropeptide Y (NPY) and various NPY-related peptides were studied on naloxone-precipitated withdrawal from morphine in rats. The withdrawal reaction was assessed using an overall motor score, including jumping, wet dog shakes and other motor-related signs as well as a nonmotor score. At doses of 3, 6 or 12 nmol, NPY strongly and dose-dependently reduced the motor score. A less prominent inhibitory effect was revealed on the nonmotor score. At 6 nmol, [Leu31,Pro34]-NPY, NPY 3-36, peptide YY and human pancreatic polypeptide all significantly attenuated the motor score, whereas NPY 13-36 was without effect. This pharmacological profile suggests that the antiwithdrawal effect of NPY is mediated via the recently cloned Y5 receptor. Our data are consistent with a potential role for NPY and Y5-like receptors in basic mechanisms and as a therapeutic target in opioid dependence and withdrawal.
Footnotes
-
Send reprint requests to: Dr. David P.D. Woldbye, Laboratory of Neuropharmacology, Department of Pharmacology, University of Copenhagen, 3 Blegdamsvej, DK-2200, Copenhagen N, Denmark
-
↵1 This work was supported by the Danish Medical Research Council (12-1343), Ivan Nielsens Foundation, Eli and Egon Larsens Foundation, the Research Grant of Einar Geert-Jørgensen and his wife Ellen Geert-Jørgensen, the Danish Psychiatric Research Foundation and the Gangsted Foundation.
- Abbreviations:
- NPY
- neuropeptide Y
- hPP
- human pancreatic polypeptide
- PYY
- peptide YY
- WDS
- wet dog shakes
- i.c.v.
- intracerebroventricular
- Received June 10, 1997.
- Accepted October 27, 1997.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|